Subacute neurological deficits and respiratory insufficiency due to intrathecal methotrexate
Background and Aim: We present a case of a 22-year-old male diagnosed with B-cell acute lymphoblastic leukemia who received intrathecal (IT) methotrexate (MTX) in addition to his systemic chemotherapy regime. During induction treatment, he presented with a rapidly progressive bilateral paresis, anarthria, and respiratory insufficiency requiring intubation. The brain magnetic resonance imaging showed bilateral lesions with diffusion restriction of the corona radiata/centrum semi-ovale without other abnormalities. He recovered spontaneously without neurological sequelae. The clinical course combined with the radiological findings is suspect for an IT-MTX-induced leukoencephalopathy.
Relevance for Patients: Although neurological deficits after IT-MTX are rare and in most cases selflimiting, it should be recognized as a cause for rapid neurological decline after excluding other causes.
[1] Surapaneni UR, Cortes JE, Thomas D, O’Brien S, Giles FJ, Koller C, et al. Central Nervous System Relapse
in Adults with Acute Lymphoblastic Leukemia. Cancer 2002;94:773-9.
[2] Larson RA. Managing CNS Disease in Adults with Acute Lymphoblastic Leukemia. Leuk Lymphoma 2018;59:3-13.
[3] Cohen IJ. Defining the Appropriate Dosage of Folinic Acid after High-Dose Methotrexate for Childhood Acute Lymphatic Leukemia that will Prevent Neurotoxicity Without Rescuing Malignant Cells in the Central Nervous System. J Pediatr Hematol Oncol 2004;26:156-63.
[4] Brugnoletti F, Morris EB, Laningham FH, Patay Z, Pauley JL, Pui CH, et al. Recurrent Intrathecal Methotrexate
Induced Neurotoxicity in an Adolescent with Acute Lymphoblastic Leukemia: Serial Clinical and Radiologic
Findings. Pediatr Blood Cancer 2009;52:293-5.
[5] Cruz-Carreras MT, Chaftari P, Shamsnia A, GuhaThakurta N, Gonzalez C. Methotrexate-Induced Leukoencephalopathy Presenting as Stroke in the Emergency Department. Clin Case Rep 2017;5:1644-8.
[6] Ziereisen F, Dan B, Azzi N, Ferster A, Damry N, Christophe C. Reversible Acute Methotrexate Leukoencephalopathy: Atypical Brain MR Imaging Features. Pediatr Radiol 2006;36:205-12.